Search Results - "JORDAN, Justin"

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline by Vogelbaum, Michael A, Brown, Paul D, Messersmith, Hans, Brastianos, Priscilla K, Burri, Stuart, Cahill, Dan, Dunn, Ian F, Gaspar, Laurie E, Gatson, Na Tosha N, Gondi, Vinai, Jordan, Justin T, Lassman, Andrew B, Maues, Julia, Mohile, Nimish, Redjal, Navid, Stevens, Glen, Sulman, Erik, van den Bent, Martin, Wallace, H James, Weinberg, Jeffrey S, Zadeh, Gelareh, Schiff, David

“…To provide guidance to clinicians regarding therapy for patients with brain metastases from solid tumors. ASCO convened an Expert Panel and conducted a…”
Get full text

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells by Karschnia, Philipp, Jordan, Justin T., Forst, Deborah A., Arrillaga-Romany, Isabel C., Batchelor, Tracy T., Baehring, Joachim M., Clement, Nathan F., Gonzalez Castro, L. Nicolas, Herlopian, Aline, Maus, Marcela V., Schwaiblmair, Michaela H., Soumerai, Jacob D., Takvorian, Ronald W., Hochberg, Ephraim P., Barnes, Jeffrey A., Abramson, Jeremy S., Frigault, Matthew J., Dietrich, Jorg

“…Chimeric antigen receptor (CAR) T cells have emerged as a promising class of cell-based immunotherapy in refractory malignancies. Neurotoxicity represents a…”
Get full text

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma by Nayak, Lakshmi, Molinaro, Annette M, Peters, Katherine, Clarke, Jennifer L, Jordan, Justin T, de Groot, John, Nghiemphu, Leia, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy R, Cote, David J, Severgnini, Mariano, Yearley, Jennifer H, Zhao, Qing, Blumenschein, Wendy M, Duda, Dan G, Muzikansky, Alona, Jain, Rakesh K, Wen, Patrick Y, Reardon, David A

“…VEGF is upregulated in glioblastoma and may contribute to immunosuppression. We performed a phase II study of pembrolizumab alone or with bevacizumab in…”
Get full text

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities by Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb

“…Early‐phase clinical trials using oral inhibitors of MEK, the mitogen‐activated protein kinase kinase, have demonstrated benefit for patients with…”
Get full text

Neurofibromatoses by Jordan, Justin T., Plotkin, Scott R.

“…The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic…”
Get full text

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial by Frigault, Matthew J., Dietrich, Jorg, Gallagher, Kathleen, Roschewski, Mark, Jordan, Justin T., Forst, Deborah, Plotkin, Scott R., Cook, Daniella, Casey, Keagan S., Lindell, Kevin A., Depinho, Gabriel D., Katsis, Katelin, Elder, Eva Lynn, Leick, Mark B., Choi, Bryan, Horick, Nora, Preffer, Frederic, Saylor, Meredith, McAfee, Steven, O'Donnell, Paul V., Spitzer, Thomas R., Dey, Bimalangshu, DeFilipp, Zachariah, El-Jawahri, Areej, Batchelor, Tracy T., Maus, Marcela V., Chen, Yi-Bin

“…CD19-directed chimerical antigen receptor T-cell (CAR-T) products have gained US Food and Drug Administration approval for systemic large B-cell lymphoma…”
Get full text

Opinion & Special Articles: Maximizing Inclusiveness and Diversity Through Virtual Residency Applications and Interviews by Budhu, Joshua A., Velazquez, Ana I., Said, Rana R., Jordan, Justin T.

Get full text

Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline by Schiff, David, Messersmith, Hans, Brastianos, Priscilla K, Brown, Paul D, Burri, Stuart, Dunn, Ian F, Gaspar, Laurie E, Gondi, Vinai, Jordan, Justin T, Maues, Julia, Mohile, Nimish, Redjal, Navid, Stevens, Glen H J, Sulman, Erik P, van den Bent, Martin, Wallace, H James, Zadeh, Gelareh, Vogelbaum, Michael A

“…American Society of Radiation Oncology (ASTRO) has developed a guideline on appropriate radiation therapy for brain metastases. ASCO has a policy and set of…”
Get full text

Neurological advocacy: Empowering the next generation of neurologists by Tamborska, Arina A., Jordan, Justin T., Michael, Benedict D., Owolabi, Mayowa O.

Get full text

Teaching NeuroImage: Subacute Quadriparesis From Intramedullary Spinal Cord Infiltrating Glioma With TERT Promoter Mutation by Gritsch, Simon, Aghajan, Yasmin, Kozanno, Liana, Chiu, Daniel, Jordan, Justin T., Frosch, Matthew P., Shankar, Ganesh, Kimberly, W. Taylor

Get full text

Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach by Terry, Anna R, Jordan, Justin T, Schwamm, Lee, Plotkin, Scott R

“…BACKGROUND AND PURPOSE—Although neurofibromatosis type 1 (NF1) may be associated with an incompletely understood vasculopathy, relative odds of stroke in this…”
Get full text

Prescription Drug Prices: An AAN Position Statement by Santoro, Jonathan D, Sico, Jason J, Burke, James F, Sarkar, Korak, Turbes, Madeline, Evans, David A, Jordan, Justin T

“…This position statement serves to establish the AAN's stance on the methods to address the cost of prescription drugs being considered by state and federal…”
Get full text

Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma by Abramson, Jeremy S., Irwin, Kelly E., Frigault, Matthew J., Dietrich, Jorg, McGree, Brianne, Jordan, Justin T., Yee, Andrew J., Chen, Yi‐Bin, Raje, Noopur S., Barnes, Jeffrey A., Davis, Benjamin

“…HIV‐positive patients have been excluded from clinical trials evaluating chimeric antigen receptor (CAR) T‐cell therapies. Herein, the authors report on 2…”
Get full text

Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis by Lu, Simeng, Yin, Zhenzhen, Chen, Jie, Wu, Limeng, Sun, Yao, Gao, Xing, Huang, Peigen, Jordan, Justin T, Plotkin, Scott R, Xu, Lei

“…NF2-related Schwannomatosis (NF2-SWN) is a disease that needs new solutions. The hallmark of NF2-SWN, a dominantly inherited neoplasia syndrome, is bilateral…”
Get full text

Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1” by Stemmer-Rachamimov, Anat O., Kozanno, Liana, Plotkin, Scott R., Jordan, Justin T., Rizzo, Joseph F.

Get full text

Histologic correlates of “Choroidal abnormalities” in Neurofibromatosis type 1 (NF1) by Stemmer-Rachamimov, Anat O., Kozanno, Liana, Plotkin, Scott R., Jordan, Justin T., 3rd Rizzo, Joseph F.

“…Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disorder characterized by proliferation of cells from neural crest origin. The most common…”
Get full text

The Brain Health Imperative in the 21st Century-A Call to Action: The AAN Brain Health Platform and Position Statement by Rost, Natalia S, Salinas, Joel, Jordan, Justin T, Banwell, Brenda, Correa, Daniel J, Said, Rana R, Selwa, Linda M, Song, Sarah, Evans, David A

“…Brain health is crucial to optimizing both the function and well-being of every person at each stage of life and is key to both individual and social progress…”
Get full text

Glioblastoma care in the elderly by Jordan, Justin T., Gerstner, Elizabeth R., Batchelor, Tracy T., Cahill, Daniel P., Plotkin, Scott R.

“…Glioblastoma is common among elderly patients, a group in which comorbidities and a poor prognosis raise important considerations when designing…”
Get full text

Primary dural lymphomas: Clinical presentation, management, and outcome by Karschnia, Philipp, Batchelor, Tracy T., Jordan, Justin T., Shaw, Brian, Winter, Sebastian F., Barbiero, Frank J., Kaulen, Leon D., Thon, Niklas, Tonn, Joerg‐Christian, Huttner, Anita J., Fulbright, Robert K., Loeffler, Jay, Dietrich, Jorg, Baehring, Joachim M.

“…Background Clinical experience is limited for primary central nervous system (CNS) lymphoma that arises from the dura mater, which is denoted with the term…”
Get full text

Hospice utilization in patients with malignant gliomas by Forst, Deborah, Adams, Eric, Nipp, Ryan, Martin, Allison, El-Jawahri, Areej, Aizer, Ayal, Jordan, Justin T

“…Despite recommendations from professional organizations supporting early hospice enrollment for patients with cancer, little research exists regarding…”
Get full text